Lipocortin 1 and the control of cPLA2 activity in A549 cells
Jamie D. Croxtall(William Harvey Research Institute), Rod Flower(Queen Mary University of London), Simon P. Newman(William Harvey Research Institute), Qam Choudhury(Queen Mary University of London)
Cited by 63
Related Papers
The development of COX2 inhibitors
|Nature Reviews Drug Discovery|2003|464
Lipocortin-1: cellular mechanisms and clinical relevance
|Trends in Pharmacological Sciences|1994|380
Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
|British Journal of Pharmacology|2000|330
A novel role for phospholipase A <sub>2</sub> isoforms in the checkpoint control of acute inflammation
|The FASEB Journal|2004|173
Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells
|British Journal of Pharmacology|2002|146